Horizon Therapeutics Public Limited Co (fka HZNP)

[Investor100]

STeady @ HZNP

Closing to $40 and the acquisition of DEPO!

On July 21, 2015, Horizon Pharma plc issued a press release announcing it has increased the value of its all-stock proposal to acquire all of the outstanding shares of common stock of Depomed, Inc. from $29.25 per share to $33.00 per share. A copy of the press release is attached hereto as Exhibit 99.1. The foregoing description is qualified in its entirety by reference to the text of such press release and is incorporated herein by reference and constitutes part of this report.

The information contained in this Item 8.01 and the attached Exhibit 99.1 are furnished to and not filed with the Securities and Exchange Commission. The foregoing description is qualified in its entirety by reference to the text of such press release and is incorporated herein by reference and constitutes part of this report.

Investor 100